HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma (Q2906475)

From EU Knowledge Graph
Revision as of 06:38, 22 October 2021 by DG Regio (talk | contribs) (‎Removed claim: budget (P474): 203,999.02 euro)
Jump to navigation Jump to search
Project Q2906475 in Portugal
Language Label Description Also known as
English
HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma
Project Q2906475 in Portugal

    Statements

    0 references
    1 January 2018
    0 references
    30 June 2021
    0 references
    INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
    0 references
    Q2997125 (Deleted Item)
    0 references

    Identifiers

    POCI-01-0145-FEDER-029030
    0 references